OKE vs TRDA · P/E 15, rev $21.70B vs P/E 12, rev $210.8M
ONEOK Inc (OKE) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the OKE and TRDA stock pages for the full models.
Not investment advice.